You are here

Practice Management


Adults who developed heart failure after their first MI had an increased risk of cancer compared with those who did not have heart failure, according to a prospective cohort study of Olmsted County, Minnesota, residents.



Recent Headlines

Mediterranean diet may improve cardiovascular outcomes

A systematic review of clinical trials found that adults who adhere to a Mediterranean diet with no restriction on fat intake may have a reduction in cardiovascular events, breast canter and type 2 diabetes compared with those on other diets.

Physical activity may lower coronary heart disease risk in younger women

Young women in the U.S. who are physically active have a lower risk of coronary heart disease, according to a prospective study that followed participants for 20 years.

Heart failure patients receiving sacubitril/valsartan have reduction in 30-day readmissions

Patients with heart failure and reduced ejection fraction who received sacubitril/valsartan (Entresto) had a 26 percent lower rate of 30-day all-cause readmissions and a 38 percent lower rate of heart failure readmissions compared with patients who received enalapril, according to an analysis of a randomized trial.

Endocrinologist responds to study suggesting low sodium intake may increase cardiovascular events

Naomi Fisher, MD, an endocrinologist at Brigham and Women’s Hospital in Boston and an associate professor at Harvard Medical School, agreed with the AHA that The Lancet study had flaws.

Meta-analysis finds no significant difference in mortality risk between diabetes medications

A random-effects network meta-analysis found that adults with type 2 diabetes had no significant difference in the risk of cardiovascular or all-cause mortality whether they took any of nine available classes of glucose-lowering medications.

FDA approves generic versions of Crestor

The FDA approved generic versions of rosuvastatin calcium (Crestor) on July 21, one day after a federal judge denied AstraZeneca’s request to extend its exclusivity for the best-selling cholesterol-lowering medication.

CMS announces 516 participating organizations in program to reduce risk of MIs and strokes

The Centers for Medicare & Medicaid Services (CMS) announced July 21 that 516 organizations in 47 states, Puerto Rico and the District of Columbia will participate in a randomized trial and program to reduce the risk of MIs and stroke in Mediciare fee-for-service beneficiaries.

PCORI provides $6.5 million in funding for comparative effectiveness research for anticoagulants

The Patient-Centered Outcomes Research Institute (PCORI) provided researchers in California and Massachusetts a total of $6.5 million in funding for two studies that will compare the effectiveness of anticoagulants in preventing blood clots in the veins and lungs.

More than 17 percent of adolescents have prediabetes

Although fewer than one percent of adolescents had diabetes, more than 17 percent had prediabetes, according to an analysis of the National Health and Nutrition Examination Survey (NHANES).

Adults who eat more subsidized foods may have an increase in cardiometabolic risk

A cross-sectional analysis found that U.S. adults who had a higher consumption of foods derived from subsidized food commodities had an increased risk of some cardiometabolic risk factors.